List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) - Overview
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Products under Development by Companies
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) - Companies Involved in Therapeutics Development
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) - Drug Profiles
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) - Dormant Projects
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) - Discontinued Products
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Number of Products under Development for Peripheral Nerve Sheath Tumor (Neurofibrosarcoma), 2021
Number of Products under Development by Companies, 2021
Products under Development by Companies, 2021
Products under Development by Companies, 2021 (Contd..1)
Number of Products by Stage and Target, 2021
Number of Products by Stage and Target, 2021 (Contd..1)
Number of Products by Stage and Mechanism of Action, 2021
Number of Products by Stage and Mechanism of Action, 2021 (Contd..1)
Number of Products by Stage and Route of Administration, 2021
Number of Products by Stage and Molecule Type, 2021
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) - Pipeline by 3SBio Inc, 2021
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) - Pipeline by Advenchen Laboratories LLC, 2021
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) - Pipeline by Aldeyra Therapeutics Inc, 2021
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) - Pipeline by Apexian Pharmaceuticals Inc, 2021
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) - Pipeline by Ascentage Pharma Group International, 2021
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) - Pipeline by AstraZeneca Plc, 2021
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) - Pipeline by BeiGene Ltd, 2021
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) - Pipeline by Bristol-Myers Squibb Co, 2021
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) - Pipeline by Calithera Biosciences Inc, 2021
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) - Pipeline by Epizyme Inc, 2021
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) - Pipeline by F. Hoffmann-La Roche Ltd, 2021
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) - Pipeline by Jiangsu Hengrui Medicine Co Ltd, 2021
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) - Pipeline by Karyopharm Therapeutics Inc, 2021
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) - Pipeline by Merck & Co Inc, 2021
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) - Pipeline by Mirati Therapeutics Inc, 2021
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) - Pipeline by Novartis AG, 2021
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) - Pipeline by Oncomatryx Biopharma SL, 2021
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) - Pipeline by Open Therapeutics LLC, 2021
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) - Pipeline by Otsuka Pharmaceutical Co Ltd, 2021
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) - Pipeline by Pfizer Inc, 2021
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) - Pipeline by Pharma Mar SA, 2021
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) - Pipeline by Plexxikon Inc, 2021
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) - Pipeline by Resverlogix Corp, 2021
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) - Pipeline by Sino Biopharmaceutical Ltd, 2021
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) - Pipeline by Sorrento Therapeutics Inc, 2021
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) - Pipeline by Vyriad Inc, 2021
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) - Dormant Projects, 2021
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) - Discontinued Products, 2021

List of Figures
Number of Products under Development for Peripheral Nerve Sheath Tumor (Neurofibrosarcoma), 2021
Number of Products under Development by Companies, 2021
Number of Products by Top 10 Targets, 2021
Number of Products by Stage and Top 10 Targets, 2021
Number of Products by Top 10 Mechanism of Actions, 2021
Number of Products by Stage and Top 10 Mechanism of Actions, 2021
Number of Products by Routes of Administration, 2021
Number of Products by Stage and Routes of Administration, 2021
Number of Products by Molecule Types, 2021
Number of Products by Stage and Molecule Types, 2021

Companies Mentioned
• 3SBio Inc
• Advenchen Laboratories LLC
• Aldeyra Therapeutics Inc
• Apexian Pharmaceuticals Inc
• Ascentage Pharma Group International
• AstraZeneca Plc
• BeiGene Ltd
• Bristol-Myers Squibb Co
• Calithera Biosciences Inc
• Epizyme Inc
• F. Hoffmann-La Roche Ltd
• Jiangsu Hengrui Medicine Co Ltd
• Karyopharm Therapeutics Inc
• Merck & Co Inc
• Mirati Therapeutics Inc
• Novartis AG
• Oncomatryx Biopharma SL
• Open Therapeutics LLC
• Otsuka Pharmaceutical Co Ltd
• Pfizer Inc
• Pharma Mar SA
• Plexxikon Inc
• Resverlogix Corp
• Sino Biopharmaceutical Ltd
• Sorrento Therapeutics Inc
• Vyriad Inc